Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study

Husseiny YM, Ramadan S, El-Helbawy A, Negmeldin F, Dway A, Abdul-Hafez HA, Hassan AY, Soued MW, Husseiny R, Hanna F. Mechanical Thrombectomy Versus Conventional Anticoagulants[...]

AuYoung M, Lasitani K, Lepule T, Samoa R, Aitaoto N. Native Hawaiian and Pacific Islander community-led survey on COVID-19 and willingness to participate in clinical[...]

Barrett LG, Gangi A, Hendifar A, Osipov A, Atkins K, Zaghiyan K, Nasseri Y, Murrell Z, Waters K, Mehta P, Zell JA, Hitchins MP, Gong[...]